This poor guy. He is so tired. U.S. President Joe Biden shakes hands with Chinese President Xi Jinping as they meet on the sidelines of the G20 leaders' summit in Bali, Indonesia, Even you Joe haters have to give this guy a lot of credit here-- he has kept some very high tech away from the China military and shook hands with it's leader. Good Job Joe--take a nap.
HOME DEPOT POSS! This is a good sign for TSCO as there was some lower overall tickets and foot traffic but inflation allows these retailers to raise prices like crazy. The Home Depot, Inc. (HD) NYSE - NYSE Delayed Price. 306.92-8.02(-2.55%) At close: 04:00PM EST 307.50+0.58(+0.19%)<--------- Pre-Market:9:03AM EST
If you follow stocks closely you can discern a trend. Cutting jobs was making stocks instantly react up and that has failed the last few job cut announcements. If you run a business which I have the first reach is for job cuts... the next cut back will be on cloud software and Tech plug ins & digital advertising... Real earn coming down so fast you get your 10% savings where you can... until there is no place left to cut... Then earnings reveal themselves.
I'm hearing whispers of a huge payout here-- Goldman Sachs: Newly-unredacted document alleges dozens of incidents of ‘sexual assault and harassment’ at firm, lawsuit says Turns out every male in power at GS is disgusting!
From 1.19% to 2.7%.... But everyone knew that would happen at the time. They were just waiting for a confirmation from your radio before they jumped in. Oh, my ES call is up 50 points from 3990. $2500/contract. PATH>>> Up 12% The children feast. >>>YOU'RE WELCOME STONEY!!!
<<2 Possible Gummies>> Kodiak Sciences initiated with an Overweight at Capital One 08:27 KOD Capital One analyst Zegbeh Jallah initiated coverage of Kodiak Sciences with an Overweight rating and $24 price target. Kodiak's long-acting anti-VEGF drug Tarcocimab, or KSI-301, is currently in Phase 3 studies for DME, wAMD and NPDR with data expected in 2023, Jallah tells investors. Data from the Phase 3 BEACON study presented in September reaffirmed KSI-301's longer-acting potential and clean safety profile and "sets positive expectations for the 2023 readouts," but Jallah believes that macro events affecting the market and a "flight of investors out of the biotech sector" led to a muted reaction to the data, the analyst added. KOD $7.25-0.31(-4.10%)11:00 AM 11/14/22 NASDAQ |$USD |Pre-Market:$7.51+0.26(+3.59%)3:48 AM Small reaction- ///////////////////// NeuroSense rises 16% on U.S. FDA clearance to begin trial of ALS treatment Watch For Gummy!// wait for GO TIME NRSN $1.580.06(+4.30%)10:59 AM 11/14/22 NASDAQ |$USD |Pre-Market:$1.74+0.17(+10.48%)<---------- BUY VAN!!!!! & Sell! Just made you 5% NRSN NeuroSense Therapeutics Ltd. $1.580.06(+4.30%)10:59 AM 11/14/22 NASDAQ |$USD |Pre-Market:$1.81+0.24(+14.92%)4:15 AM
Oh Van I hate to do this you're going to hitch your flagging reputation to PATH really. Has it come to this. No original research No thesis No concept no trade guidelines what is your objective how long? wrong sector alright fine when PATH opens I'll begin tracking. I think you are making a mistake.
And so it starts I have been looking for the contagion connection between Bitcoin and tech stocks and I found it! Cathie Wood purchases shares of the tumbling Grayscale Bitcoin Trust Nov. 15, 2022 9:23 AM ET Grayscale Bitcoin Trust (BTC)
These Jana brothers are smart. My mom dealt with them for years. I always take note of where they are dipping their toes. We should break out these names for individual research: A- FRPT what is a fresh pet? B- New Relic I believe is Nuclear! C- BlackSky? Cool name.
Last 4 days calls: PATH--- HUGE WINNER DNA---Already up 7% from $2.53 ES--- 50 POINTS!!! QQQ---- $6 today alone IGT --- HUGE WINNER PETQ--- HUGE WINNER HD---- HUGE WINNER/ perfect timing GME OPTIONS--- 200% GAIN!! AND NO LOSERS! #1 for a reason